Pieris Pharma (PIRS) Reports Q1 Loss of $0.19/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. SPY
8. AAPL
9. LITE
10. NVT

Go back to Pieris Pharma (PIRS) Reports Q1 Loss of $0.19/Share

Pieris Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2017 and Provides Corporate Update

May 10, 2017 5:36 PM EDT

BOSTON, MA -- (Marketwired) -- 05/10/17 -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other diseases, today reported financial results for the first quarter of 2017 and provided an update on the Company's recent developments, including:

Secured global and transformative alliances in our two core therapeutic areas of immuno-oncology and respiratory diseases with Servier and... More